Organon is a science-based global pharmaceutical company that is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Co.'s operations are principally managed on a products basis in one operating segment: the Organon Products segment. Co. sells these products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. The OGN stock yearly return is shown above.
The yearly return on the OGN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the OGN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|